 | 
|
| |
|
Titel: Kronisk daglig huvudvärk - ett folkhälsoproblem [summary] (serie: Tema huvudvärk) 2007 nr 23 sid 1820-4
|
Summary:
Approximately 4% of the general population suffers from chronic daily headache (CDH), which is a generic term for a group of different disorders. The epidemiology, present knowledge on pathophysiology, clinical manifestations and guidelines for treatment of chronic tension-type headache and medication overuse headache are reviewed. There is also a discussion on the fact that, in Sweden, 9% of migraineurs do not recover between attacks, commonly as a result of chronic migraine. The first Swedish case series of new daily persistent headache is presented. Studies are highlighted in support of the joint use of non-pharmacological strategies and medication in the treatment of CDH.
Mattias Linde, Emma Nordlander, Jane Carlsson
Correspondence: Mattias Linde, Cephalea Huvudvärkscentrum, Läkarhuset, Södra vägen 27, SE-41135 Göteborg, Sweden mattias.linde@neuro.gu.se
Referenser:
1.Colas R, Munoz P, Temprano R, Gomez C, Pascual J. Chronic daily headache with analgesic overuse: epidemiology and impact on quality of life. Neurology 2004;62(8):1338-42.
2.Castillo J, Munoz P, Guitera V, Pascual J. Epidemiology of chronic daily headache in the general population. Headache 1999;93(3):190-6.
3.Hershey A, Kabbouche M, Powers S. Chronic daily headaches in children. Curr Pain Headache Rep 2006;10(5):370-6.
4.Rasmussen BK. Epidemiology of headache. Cephalalgia 1995;15(1):45-68.
5.Scher A, Stewart W, Liberman J, Lipton R. Prevalence of frequent headache in a population sample. Headache 1998;38(7):497-506.
6.Wiendels N, Knuistingh Neven A, Rosendaal F, Spinhoven P, Zitman F, Assendelft W, et al. Chronic frequent headache in the general population: prevalence and associated factors. Cephalalgia 2006;26(12):1434-42.
7.Zwart J, Dyb G, Hagen K, Svebak S, Holmen J. Analgesic use: a predictor of chronic pain and medication overuse headache: the Head-HUNT Study. Neurology 2003;61(2):160-4.
8.Headache Classification Subcommittee of the International Headache Society. The international classification of headache disorders. 2nd edition. Cephalalgia. 2004;24 Suppl 1:1-160.
9.Jensen R, Becker W. Symptomatology of chronic tension-type headache. In: Olesen J, Goadsby P, Ramadan N, Tfelt-Hansen P, Welch K, editors. The Headaches. Third edition ed. Philadelphia: Lippincott Williams & Wilkins; 2006. p. 693-700.
10.Schwartz B, Stewart W, Simon D, Lipton R. Epidemiology of tension-type headache. JAMA 1998;279(5):381-3.
11.Scher A, Stewart W, Ricci J, Lipton R. Factors associated with the onset and remission of chronic daily headache in a population-based study. Pain 2003;106(1-2):81-9.
12.Solomon S, Lipton R, Newman L. Clinical features of chronic daily headache. Headache 1992;32(7):325-9.
13.Ulrich V, Russell M, Jensen R, Olesen J. A comparison of tension-type headache in migraineurs and in non-migraineurs: a population-based study. Pain 1996;67(2-3):501-6.
14.Ashina S, Bendtsen L, Ashina M. Pathophysiology of tension-type headache. Curr Pain Headache Rep 2005;9(6):415-22.
15.Ashina S, Bendtsen L, Ashina M, Magerl W, Jensen R. Generalized hyperalgesia in patients with chronic tension-type headache. Cephalalgia 2006;26(8):940-8.
16.Peatfield R, Edmeads J. General approach to treatment of tension-type headache. In: Olesen J, Goadsby P, Ramadan N, Tfelt-Hansen P, Welch K, editors. The Headaches. Third edition ed. Philadelphia: Lippincott Williams & Wilkins; 2006. p. 707-709.
17.Bendtsen L, Buchgreitz L, Ashina M, Jensen R. Combination of loe-dose mirtazapine and ibuprofen for prophylaxis of chronic tension-type headache. Eur J Neurol 2007;14(2):187-93.
18.Torelli P, Jensen R, Olesen J. Phsyiotherapy for tension-type headache: a controlled study. Cephalalgia 2004;24:29-36.
19.Söderberg E, Carlsson J, Stener-Victorin E. Chronic tension-type headache treated with acupuncture, physical training and relaxation training. Between-group differences. Cephalalgia 2006;26(11):1320-9.
20.Larsson B, Carlsson J. A school-based, nurse-administered relaxation training for children with chronic tension-type headache. J Pediatr Psychol 1996;21(5):603-14.
21.Bendtsen L, Jensen R, Olesen J. Amitriptyline, a combined serotonin and noradrenaline re-uptake inhibitor, reduces exteroceptive suppression of temporal muscle activity in patients with chronic tension-type headache. J Neurol Neurosurg Psychiatry 1996;61(3):285-90.
22.Bendtsen L, Jensen R. Mirtazapine is effective in the prophylactic treatment of chronic tension-type headache. Neurology 2004;62(10):1706-11.
23.Evans R. New daily persistent headache. Curr Pain Headache Rep 2003;7(4):303-7.
24.Li D, Rozen T. The clinical characteristics of new daily persistent headache. Cephalalgia 2002;22(1):66-9.
25.Scalas C, Calistri L. Chronic daily headache in a paediatric headache centre. J Headache Pain 2005;6(4):274-6.
26.Linde M, Dahlöf C. Attitudes and burden of disease among self-considered migraineurs. A nation-wide, population-based survey in Sweden. Cephalalgia 2004;24:455-465.
27.Linde M. Migraine: a review and future directions for treatment. Acta Neurol Scand 2006;114(2):71-83.
28.Mathew N. Transformed or evolutional migraine. Headache 1987;27:305-6.
29.Bigal M, Tepper S, Sheftell F, Rapoport A, Lipton R. Field testing alternative criteria for chronic migraine. Cephalalgia 2006;26(4):477-82.
30.Matharu M, Bartsch T, Ward N, Frackowiak R, Weiner R, Goadsby P. Central neuromodulation in chronic migraine patients with suboccipital stimulators: a PET study. Brain 2004;127:220-30.
31.de Tommaso M, Losito L, Difruscolo O, Libro G, Guido M, Livrea P. Changes in cortical processing of pain in chronic migraine. Headache 2005;45(9):1208-18.
32.De Marinis M, Pujia A, Colaizzo E, Accornero N. The blink reflex in "chronic migraine". Clin Neurophysiol 2007;118(2):457-63.
33.Ashkenazi A, Sholtow M, Shaw J, Burstein R, Young W. Identifying cutaneous allodynia in chronic migraine using a practical clinical method. Cephalalgia 2007;27(2):111-7.
34.Evers S, Afra J, Frese A, Goadsby P, Linde M, May A, et al. EFNS guideline on the drug treatment of migraine - report of an EFNS task force. Eur J Neurol 2006;13(6):560-72.
35.Holroyd K, Penzien D, Lipchik G. Behavioral management of headache. In: Silberstein S, Lipton R, Dalessio D, editors. Wolff´s Headache and other head pain. Seventh ed. ed. Oxford: Oxford University Press; 2001. p. 562-98.
36.Reid G, McGrath P. Psychological treatments for migraine. Biomed Pharmacother 1996;50:58-63.
37.McGrath P, Holroyd K, Sorbi M. Psychological and behavioral treatments of migraine. In: Olesen J, Tfelt-Hansen P, Welch K, editors. The Headaches. Second edition ed. Philadelphia: Lippincott Williams & Wilkins; 2000. p. 371-78.
38.Hermann C, Kim M, Blanchard E. Behavioral and prophylactic pharmacological intevention studies of pediatric migraine: an exploratory meta-analysis. Pain 1995;60:239-56.
39.Larsson B, Carlsson J, Fichtel Å, Melin L. Relaxation treatment of adolescent headache sufferers: Results from a school-based replication series. Headache 2005;45:692-704.
40.Marcus D, Scharff L, Mercer S, Turk D. Nonpharmacological treatment of migraine: incremental utility of physical therapy with relaxation and thermal feedback. Cephalalgia 1998;18:266-72.
41.Vincent C. A controlled trial of the treatment of migraine by acupuncture. Clin J Pain 1989;5:305-12.
42.Melchart D, Linde K, Fischer P, Berman B, White A, Vickers A, et al. Acupuncture for idiopathic headache (Cochrane Review). In. Issue 4 ed: Update Software; 2002.
43.Hesse J, Mögelvang B, Simonsen H. Acupuncture versus metoprolol in migraine prophylaxis: a randomised trial of trigger point inactivation. J Intern Med 1994;235:451-6.
44.Allais G, De Lorenzo C, Quirico P, Airola G, Tolardo G, Mana O, et al. Acupuncture in the prophylactic treatment of migraine without aura: a comparison with flunarizine. Headache 2002;42:855-61.
45.Neususs K. Physical activity and fitness in patients with headache disorders. J Sports Med 1997;18(8):607-11.
46.Van-Gijn J. Relief of common migraine by exercise. J Neurol Neurosurg Psychiatry 1987;50:1770-1.
47.Kumar K. Exercise for prophylaxis of migraine. Headache 1988;28:228.
48.Osün Narin S, Pinar L, Erbas D, Oztürk V, Idiman F. The effects of exercise and exercise-related changes in blood nitric oxide level on migraine headache. Clin Rehabil 2003;17:624-30.
49.Köseoglu E, Akboyraz A, Souyer A, Ersoy A. Aerobic exercise and plasma endorphin levels in patients with migrainous headache without aura. Cephalalgia 2003;23:972-76.
50.Donna-Marie C, Lockett M, Campbell J. The effects on aerobic exercise on migraine. Headache 1992;32:50-4.
51.Lambert R, Burnett D. Prevention of exercise induced migraine by quantitative warm-up. Headache 1991;31:612-8.
52.Rooke E. Benign exertional headache. Med Clin North Am 1968:373-82.
53.Thompson J. Exercise-induced migraine prodrome symtoms. Headache 1987;27:250-1.
54.Diener H, Silberstein S. Medication overuse headache. In: Olesen J, Goadsby P, Ramadan N, Tfelt-Hansen P, Welch K, editors. The Headaches. Philadelphia: Lippincott Williams & Wilkins; 2006. p. 971-80.
55.Grazzi L, Andrasik F. Medication-overuse headache: description, treatment, and relapse prevention. Curr Pain Headache Rep 2006;10(1):71-7.
56.Meskunas C, Tepper S, Rapoport A, Sheftell F, Bigal M. Medications associated with probable medication overuse headache reported in a tertiary care headache center over a 15-year period. Headache 2006;46(5):766-72.
57.Linton-Dahlöf P, Linde M, Dahlöf C. Withdrawal therapy improves chronic daily headache associated with long-term misuse of headache medication: a retrospective study. Cephalalgia 2000;20:658-62.
58.Diener H, Katsarava Z. Analgesic/abortive overuse and misuse in chronic daily headache. Curr Pain Headache Rep 2001;5(6):545-50.
59.Katsarava Z, Diener H, Limmroth V. Medication overuse headache: a focus on analgesics, ergot alkaloids and triptans. Drug Saf 2001;24(12):921-7.
60.Katsarava Z, Schneeweiss S, Kurth T, Kroener U, Fritsche G, Eikermann A, et al. Incidence and predictors for chronicity of headache in patients with episodic migraine. Neurology 2004;62(5):788-90.
61.Dobson C, Tohyama Y, Diksic M, Hamel E. Effects of acute or chronic administration of anti-migraine drugs sumatriptan and zolmitriptan on serotonin synthesis in the rat brain. Cephalalgia 2004;24(1):2-11.
62.Linde M, Elam M, Lundblad L, Olausson H, Dahlöf C. Sumatriptan (5-HT1B/1D-agonist) causes a transient allodynia. Cephalalgia 2004;24:1057-66.
63.Reuter U, Salomone S, Ickenstein G, Waeber C. Effects of chronic sumatriptan and zolmitriptan treatment on 5-HT receptor expression and function in rats. Cephalalgia 2004;24(5):398-407.
64.Welch K, Nagesh V, Rozell K. Functional MRI of chronic daily headache. Cephalalgia 1999;19:462-3.
65.Griffiths R, Woodson P. Reinforcing properties of caffeine: studies in humans and laboratory animals. Pharmacol Biochem Behav 1988;29(2):419-27.
66.Ziegler D. Opiate and opioid use in patients with refractory headache. Cephalalgia 1994;14(1):5-10.
67.Zeeberg P, Olesen J, Jensen R. Probable medication-overuse headache: the effect of a 2-month drug-free period. Neurology 2006;66(12):1894-8.
68.Krymchantowski A, Moreira P. Out-patient detoxification in chronic migraine: comparison of strategies. Cephalalgia 2003;23(10):982-93.
69.Rossi P, Di Lorenzo C, Faroni J, Cesarino F, Nappi G. Advice alone vs. structured detoxification programmes for medication overuse headache: a prospective, randomized, open-label trial in transformed migraine patients with low medical needs. Cephalalgia 2006;26(9):1097-105.
70.Diener H, Haab J, Peters C, Ried S, Dichgans J, Pilgrim A. Subcutaneous sumatriptan in the treatment of headache during withdrawal from drug-induced headache. Headache 1991;31(4):205-9.
71.Grazzi L, Andrasik F, D'Amico D, Leone M, Usai S, Kass S, et al. Behavioral and pharmacologic treatment of transformed migraine with analgesic overuse: outcome at 3 years. Headache 2002;42(6):483-90.
72.Linde M, Mellberg A, Dahlöf C. Subcutaneous sumatriptan provides symptomatic relief at any pain intensity or time during the migraine attack. Cephalalgia 2006;26:113-21.
73.Katsarava Z, Limmroth V, Finke M, Diener H, Fritsche G. Rates and predictors for relapse in medication overuse headache: a 1-year prospective study. Neurology 2003;60(10):1682-3.
74.Schnider P, Aull S, Baumgartner C, Marterer A, Wober C, Zeiler K, et al. Long-term outcome of patients with headache and drug abuse after inpatient withdrawal: five-year follow-up. Cephalalgia 1996;16(7):481-5.
 1820 |
 1821 |
 1822 |
 1823 |
 1824 |